Search Results

There are 12077 results for: content related to: Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure

  1. You have full text access to this OnlineOpen article
    Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer

    BJU International

    Volume 117, Issue 2, February 2016, Pages: 215–225, Jack Schalken and John M. Fitzpatrick

    Version of Record online : 6 JUN 2015, DOI: 10.1111/bju.13123

  2. You have free access to this content
    Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?

    BJU International

    Volume 115, Issue 3, March 2015, Pages: 364–372, Nicolas Mottet, Noel Clarke, Maria De Santis, Filiberto Zattoni, Juan Morote and Steven Joniau

    Version of Record online : 15 JUL 2014, DOI: 10.1111/bju.12736

  3. You have free access to this content
    Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC)

    BJU International

    Volume 116, Issue 1, July 2015, Pages: 17–29, Guru Sonpavde, Christopher G. Wang, Matthew D. Galsky, William K. Oh and Andrew J. Armstrong

    Version of Record online : 23 OCT 2014, DOI: 10.1111/bju.12867

  4. You have free access to this content
    The utility of prostate-specific antigen in the management of advanced prostate cancer

    BJU International

    Volume 112, Issue 5, September 2013, Pages: 548–560, E. David Crawford, Charles L. Bennett, Gerald L. Andriole, Marc B. Garnick and Daniel P. Petrylak

    Version of Record online : 4 JUL 2013, DOI: 10.1111/bju.12061

  5. Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancer

    BJU International

    Ben Y. Zhang, Shaun M. Riska, Douglas W. Mahoney, Brian A. Costello, Rhea Kohli, Jorge F. Quevedo, James R. Cerhan and Manish Kohli

    Version of Record online : 6 AUG 2016, DOI: 10.1111/bju.13584

  6. You have free access to this content
    Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer

    BJU International

    Volume 111, Issue 8, June 2013, Pages: 1269–1280, William L. Dahut, Ravi A. Madan, Joyson J. Karakunnel, David Adelberg, James L. Gulley, Ismail B. Turkbey, Cindy H. Chau, Shawn D. Spencer, Marcia Mulquin, John Wright, Howard L. Parnes, Seth M. Steinberg, Peter L. Choyke and William D. Figg

    Version of Record online : 18 FEB 2013, DOI: 10.1111/j.1464-410X.2012.11667.x

  7. You have free access to this content
    Is there an antiandrogen withdrawal syndrome with enzalutamide?

    BJU International

    Volume 115, Issue 3, March 2015, Pages: 373–380, Alejo Rodriguez-Vida, Diletta Bianchini, Mieke Van Hemelrijck, Simon Hughes, Zafar Malik, Thomas Powles, Amit Bahl, Sarah Rudman, Heather Payne, Johann de Bono and Simon Chowdhury

    Version of Record online : 24 OCT 2014, DOI: 10.1111/bju.12826

  8. You have free access to this content
    Role of Immunotherapy in Castration-Resistant Prostate Cancer (CRPC)

    BJU International

    Volume 113, Issue 3, March 2014, Pages: 367–375, Cristina Suárez, Rafael Morales-Barrera, Victor Ramos, Isaac Núñez, Claudia Valverde, Jacques Planas, Juan Morote, Xavier Maldonado and Joan Carles

    Version of Record online : 12 APR 2013, DOI: 10.1111/bju.12110

  9. You have free access to this content
    Clinical trial risk in castration-resistant prostate cancer: immunotherapies show promise

    BJU International

    Volume 113, Issue 5b, May 2014, Pages: E82–E89, Alessandro Tenuta, Laurence Klotz and Jayson L. Parker

    Version of Record online : 2 DEC 2013, DOI: 10.1111/bju.12309

  10. Bone Scan Index predicts outcome in patients with metastatic hormone-sensitive prostate cancer

    BJU International

    Volume 117, Issue 5, May 2016, Pages: 748–753, Mads H. Poulsen, Janne Rasmussen, Lars Edenbrandt, Poul F. Høilund-Carlsen, Oke Gerke, Allan Johansen and Lars Lund

    Version of Record online : 13 JUN 2015, DOI: 10.1111/bju.13160

  11. You have free access to this content
    Adverse effects of androgen-deprivation therapy in prostate cancer and their management

    BJU International

    Volume 115, Issue S5, April 2015, Pages: 3–13, Handoo Rhee, Jennifer H. Gunter, Peter Heathcote, Ken Ho, Phillip Stricker, Niall M. Corcoran and Colleen C. Nelson

    Version of Record online : 1 APR 2015, DOI: 10.1111/bju.12964

  12. A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer

    BJU International

    Volume 116, Issue 4, October 2015, Pages: 546–555, Fatima H. Karzai, Andrea B. Apolo, Liang Cao, Ravi A. Madan, David E. Adelberg, Howard Parnes, David G. McLeod, Nancy Harold, Cody Peer, Yunkai Yu, Yusuke Tomita, Min-Jung Lee, Sunmin Lee, Jane B. Trepel, James L. Gulley, William D. Figg and William L. Dahut

    Version of Record online : 8 JUN 2015, DOI: 10.1111/bju.12986

  13. You have full text access to this OnlineOpen article
    Enzalutamide in European and North American men participating in the AFFIRM trial

    BJU International

    Volume 115, Issue 1, January 2015, Pages: 41–49, Axel S. Merseburger, Howard I. Scher, Joaquim Bellmunt, Kurt Miller, Peter F.A. Mulders, Arnulf Stenzl, Cora N. Sternberg, Karim Fizazi, Mohammad Hirmand, Billy Franks, Gabriel P. Haas, Johann de Bono and Ronald de Wit

    Version of Record online : 23 OCT 2014, DOI: 10.1111/bju.12898

  14. You have free access to this content
    Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study

    BJU International

    Volume 115, Issue 1, January 2015, Pages: 65–73, Florence Joly, Remy Delva, Loïc Mourey, Emmanuel Sevin, Emmanuelle Bompas, Lionel Vedrine, Alain Ravaud, Jean-Christophe Eymard, Nicole Tubiana-Mathieu, Claude Linassier, Nadine Houede, Aline Guillot, François Ringensen, Oana Cojocarasu, Bruno Valenza, Alexandra Leconte, Stéphanie Lheureux, Bénédicte Clarisse and Stéphane Oudard

    Version of Record online : 15 DEC 2014, DOI: 10.1111/bju.12552

  15. Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer

    BJU International

    Volume 118, Issue 4, October 2016, Pages: 570–577, Stephen J. Freedland, Lauren E. Howard, Brian T. Hanyok, Vishnu K. Kadiyala, Jameson Y. Kuang, Colette A. Whitney, Floyd R. Wilks, Christopher J. Kane, Martha K. Terris, Christopher L. Amling, Matthew R. Cooperberg, William J. Aronson and Daniel M. Moreira

    Version of Record online : 8 FEB 2016, DOI: 10.1111/bju.13405

  16. You have free access to this content
    Avoiding obsolescence in advanced prostate cancer management: a guide for urologists

    BJU International

    Volume 115, Issue 2, February 2015, Pages: 188–197, Neal D. Shore, Lawrence Karsh, Leonard G. Gomella, Thomas E. Keane, Raoul S. Concepcion and E. David Crawford

    Version of Record online : 26 JUN 2014, DOI: 10.1111/bju.12665

  17. You have full text access to this OnlineOpen article
    Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer

    BJU International

    Andrew S. McDaniel, Roberta Ferraldeschi, Rachel Krupa, Mark Landers, Ryon Graf, Jessica Louw, Adam Jendrisak, Natalee Bales, Dena Marrinucci, Zafeiris Zafeiriou, Penelope Flohr, Spyridon Sideris, Mateus Crespo, Ines Figueiredo, Joaquin Mateo, Johann S. de Bono, Ryan Dittamore, Scott A. Tomlins and Gerhardt Attard

    Version of Record online : 18 SEP 2016, DOI: 10.1111/bju.13631

  18. You have free access to this content
    Inflammation and prostate cancer: the role of interleukin 6 (IL-6)

    BJU International

    Volume 113, Issue 6, June 2014, Pages: 986–992, Daniel P. Nguyen, Jinyi Li and Ashutosh K. Tewari

    Version of Record online : 6 JUN 2014, DOI: 10.1111/bju.12452

  19. You have free access to this content
    Bladder outlet obstruction (BOO) in men with castration-resistant prostate cancer

    BJU International

    Volume 114, Issue 1, July 2014, Pages: 62–66, Maximilian Rom, Matthias Waldert, Georg Schatzl, Natalia Swietek, Shahrokh F. Shariat and Tobias Klatte

    Version of Record online : 2 DEC 2013, DOI: 10.1111/bju.12438

  20. You have free access to this content
    Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue

    BJU International

    Volume 113, Issue 5, May 2014, Pages: 822–829, Fernando Korkes, Marilia Germanos de Castro, Stenio de Cassio Zequi, Lívia Nardi, Auro Del Giglio and Antonio Carlos de Lima Pompeo

    Version of Record online : 31 OCT 2013, DOI: 10.1111/bju.12339